IDEAYA Biosciences, Inc. announced the appointment of Joshua Bleharski, Ph.D., as Chief Financial Officer on February 10, 2025. Dr. Bleharski is anticipated to transition into his new role by early May.
Dr. Bleharski joins IDEAYA from J.P. Morgan, where he spent nearly 17 years as a Managing Director and Global Co-Head of Biopharma with their Healthcare Investment Banking group. In this role, he advised clients on capital markets transactions, corporate strategy, and other investment banking services, representing over $65 billion in value.
This key executive hire is expected to be invaluable as IDEAYA advances its broad precision medicine oncology pipeline and builds a fully integrated biotechnology company. His expertise in corporate finance, public financing, and strategic transactions will support the company's growth vision.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.